Search Results - "Karanfilski, O."

Single nucleotide polymorphisms of the inflamatory cytokine genes: interleukin-1B, tumor necrosis factors-A and tumor necrosis factor-B in adult patients with immune thrombocytopenia by Pavkovic, M, Angelovic, R, Popova-Simjanovska, M, Karanfilski, O, Trpkovska-Terzieva, S, Sotirova, T, Cevreska, L, Stojanovic, A

“…Immune thrombocytopenia (ITP) is an autoimmune disease characterized by thrombocytopenia due to platelet autoantibodies, causing an accelerated clearance of…”
Get more information

Molecular Diagnostics of β-Thalassemia by Atanasovska, B, Bozhinovski, G, Chakalova, L, Kocheva, S, Karanfilski, O, Plaseska-Karanfiska, D

“…A high-quality hemoglobinopathy diagnosis is based on the results of a number of tests including assays for molecular identification of causative mutations. We…”
Get full text

Molecular Diagnostics of ß-Thalassemia by Plaseska-Karanfilska, Dijana, Atanasovska, B, Bozhinovski, G, Chakalova, L, Kocheva, S, Karanfilski, O

“…A high-quality hemoglobinopathy diagnosis is based on the results of a number of tests including assays for molecular identification of causative mutations. We…”
Get full text

P009 “High-risk” patients with aggressive non-Hodgkin lymphoma should benefit from autologous stem cell transplantation in first remission (single-centre experience) by Genadieva Stavrik, S, Cevreska, L, Stojanoski, Z, Pivkova, A, Stojanovik, A, Krstevska Balkanov, S, Karanfilski, O, Georgievski, B

Get full text

P172 Early stage HD patients have improved outcome following combined modality treatment by Karanfilski, O, Stankovic, S, Sotirova, T, Trajkova, S, Trpkovska-Terzieva, S, Latifi, A, Stojanovic, A

Get full text

P062 Results of RCHOP6 or RCHOP8 study in the treatment of patients with diffuse large B-cell lymphoma – single institution study by Trajkova, S, Stojanovic, A, Panovska-Stavridis, I, Pivkova, A, Georgievski, B, Karanfilski, O, Cevreska, L

Get full text

P101 Antimycotic prophylaxis in stem cell recipients – single center expirience by Stojanoski, Z, Cevreska, L, Genadieva-Stavrik, S, Pivkova, A, Ivanovski, M, Karanfilski, O, Georgievski, B

Get full text

Association of polymorphisms in human platelet antigens with idiopathic thrombocytopenic purpura in Macedonians by Pavkovic, M, Stojanovic, A, Karanfilski, O, Cevreska, L, Spiroski, M

“…Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disease characterized by thrombocytopenia due to the presence of platelet autoantibodies specific…”
Get full text

PB2343 INDIVIDUALIZED TREATMENT AGAINST BACTERIAL INFECTIONS IN STEM CELL RECIPIENTS ‐ SINGLE CENTER EXPERIENCE by Stojanoski, Z., Pivkova, A., Panovska‐Stavridis, I., Cadievski, L., Georgievski, B., Ivanovski, M., Karanfilski, O., Cevreska, L.

“…Background: Multidrug resistant (MDR) bacteria are increasingly frequent in HSCT recipients, but significant differences in etiology of bacterial infections…”
Get full text

PB2003 ADDED RADIOTHERAPY IMPROVES PROGNOSIS IN HD PATIENTS TREATED WITH ABVD by Karanfilski, O., Amzai, G., Trpkovska Terzieva, S., Pavkovik, M., Sotirova, T., Genadieva Stavrik, S., Krstevska Balkanov, S., Cvetanoski, M., Ridova, N., Kocoski, B., Stojanovik, A.

“…Background: Results from many analyses and trials have shown that combined modality treatment contributes to better vital statistics for HD patients, compared…”
Get full text

PF476 SALVAGE OPTIONS FOR HD PATIENTS FAILING INITIAL ABVD TREATMENT by Karanfilski, O., Amzai, G., Trpkovska Terzieva, S., Pavkovik, M., Sotirova, T., Genadieva Stavrik, S., Stojanoski, Z., Milovska, D., Ristevska, T., Stojanovska, S., Cadievski, L., Stojanovik, A.

“…Background: The establishing of ABVD as the standard in treatment of HD patients, significantly improved their prognosis, elevating the proportion of cured…”
Get full text

PB1913 CIRS SCORE AS A RELIABLE COMORBIDITY EVALUATION TOOL MAY INFLUENCE THERAPEUTIC DECISIONS IN ELDERLY CLL PATIENTS by Amzai, G., Karanfilski, O., Genadieva Stavric, S., Sotirova, T., Trpkovska Terzieva, S., Pavkovic, M., Milovska, D., Muca, A., Kocovski, B., Stojanovic, A.

“…Background: Chronic lymphocytic leukemia (CLL) is the most common lymphoproliferative disorder in the elderly population and many of these patients have…”
Get full text

Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphanates by Pavkovic, M, Petrushevska, G, Jovanovic, R, Karanfilski, O, Cevreska, L, Stankovic, S, Stojanovic, A

“…Bisphosphonates are pyrophosphate analogues which inhibit osteoclastic activity. Long term use of bisphosphonates has recently been associated with…”
Get full text

INTENSIVE PLASMA EXCHANGE WAKES UP PATIENT WITH TTP IN COMA by Stankovic, S.G., Cevreska, L., Karanfilski, O.

Get full text

Congenital and Acquired Chronic Neutropenias: Challenges, Perspectives and Implementation of the EuNet‐INNOCHRON Action by Papadaki, Helen A., Mavroudi, Irene, Almeida, Antonio, Bux, Juergen, Cichy, Joanna, Dale, David C., Donadieu, Jean, Höglund, Petter, Karanfilski, Oliver, Mecucci, Cristina, Palmblad, Jan, Skokowa, Julia, Stamatopoulos, Kostas, Touw, Ivo, Warren, Alan J., Welte, Karl, Zeidler, Cornelia, Dufour, Carlo

Get full text

Intermediate VP-16 (1gr/[m.sup.2]) plus G-CSF (10 mcg/kg) or cyclophosphamide (3gr/[m.sup.2]) plus G-CSF (10mcg/kg) for progenitor cell mobilisation in lymphoma patients by Georgievski, B, Milenkov, V, Stavrik, S. Genadieva, Stojanoski, Z, Pivkova, A, Cevreska, L, Karanfilski, O

“…Cyclophosphamide (CTX) 3gr/[m.sup.2] plus G-CSF 10mcg/[m.sup.2] is commonly used regimen for mobilization of peripheral blood progenitor cells (PBPC) to…”
Get full text

Intermediate VP-16 for progenitor cell mobilisation in lymphoma patients by Pivkova, A, Stavrik, S. Genadieva, Stojanoski, Z, Cevreska, L, Karanfilski, O, Milenkov, V, Georgievski, B

“…Cyclophosphamide (CTX) 3gr/[m.sup.2] plus G-CSF 10mcg/[m.sup.2] is commonly used regimen for mobilization of peripheral blood progenitor cells (PBPC) to…”
Get full text

Molecular Diagnostics of ?-Thalassemia by Plaseska-Karanfilska, Dijana, Atanasovska, B, Bozhinovski, G, Chakalova, L, Kocheva, S, Karanfilski, O

“…A high-quality hemoglobinopathy diagnosis is based on the results of a number of tests including assays for molecular identification of causative mutations. We…”
Get full text

Autoimmune hemolytic anemia in chronic lymphocytic leukemia by Stojcevski, T, Saso, R, Stojanoski, R, Karanfilski, O

Get more information

The Incidence and Prognostic Value of Histologic Changes in Bone Marrow Biopsies from Patients with Non-Hodgkin's Lymphoma by Petruševska, G., Stojanović, A., Cevrevska, L., Stanković, S., Georgievski, B., Jovanović, R., Hagi-Pecova, L., Karanfilski, O., Jovanovski, M.

Get full text